Send us a text

This MedEvidence Monday Minute episode uncovers a remarkable development in cardiovascular health - a weight loss drug called Ozempic, which, according to study results, reduces cardiovascular complications. We unpack the implications of these results, the science behind the drug, and its impact on cholesterol, blood pressure, and sugar levels.

Dr. Koren also shines a light on the potential side effects of Ozempic and emphasizes the critical role of a physician's guidance before opting for such medications. This episode isn't just about Ozempic but also provides a broader perspective on the role of clinical trials in advancing medical research. Dr. Koren offers valuable advice if you've ever wondered how to manage cardiovascular risk factors. You'll learn that understanding individual problems and working with a professional to achieve health goals is key. Don't miss out on Dr. Koren's expert take on this groundbreaking research and its potential to transform cardiovascular health.

Recording Date: November 13, 2023

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!